Skip to content

Clinical trials

Phase 2 Lymphoma, T-Cell trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Phase: Phase 2 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20112
20182
20193
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The Lymphoma Academic Research Organisation3
Celgene2
miRagen Therapeutics, Inc.2
Acrotech Biopharma Inc.1
BeiGene1
French Innovative Leukemia Organisation1
Innate Pharma1
Janssen Research & Development, LLC1
Prescient Therapeutics, Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell13
Lymphoma, T-Cell, Cutaneous6
Lymphoma, T-Cell, Peripheral5
Lymphoma4
Lymphoma, Non-Hodgkin4
Mycosis Fungoides4
Recurrence3
Immune System Diseases2
Immunoproliferative Disorders2
Lymphatic Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.